Valatrex 250 mg, 500 mg FC tablets

Valatrex 250 mg, 500 mg FC tablets

S4
PDF Leaflet Revision Date: 28 July 2023

API: Valaciclovir | Company: Sandoz Sa

Clinical Summary

Quick overview from the medicine insert

Indication

Treatment of herpes zoster and recurrent genital herpes.

Dosage (summary)

Herpes zoster: 1000 mg TID for 7 days; Genital herpes: 500 mg BID for 5 days.

Special Populations

  • Elderly
  • Renal impairment
  • Hepatic impairment

Pregnancy & Breastfeeding

Safety not established; caution advised during pregnancy and lactation.

Key Drug Interactions

  • Cimetidine
  • Probenecid
  • Nephrotoxic drugs

Contraindications

  • Hypersensitivity to valaciclovir or aciclovir

Common side effects

  • Headache
  • Dizziness
  • Vomiting
  • Diarrhoea
  • Skin rashes

Counselling Points

  • Maintain adequate hydration
  • Avoid intercourse during outbreaks
  • Monitor for neurological symptoms

Serious warnings

  • Risk of neurological side effects in renal impairment
  • Serious skin reactions (DRESS, AGEP)
Important Disclaimer

The Valatrex 250 mg, 500 mg FC tablets professional information leaflet below is the property of Sandoz Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

Healthcare Professionals Only

This content is for registered healthcare professionals

Sign in or create a free account to read the full package insert.

Free for HPCSA-registered professionals. Powered by Medinsert.

Successfully Stashed! 💊

This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

View My Favourites